Combining genomic analyses with tumour-derived slice cultures for the characterization of an EGFR-activating kinase mutation in a case of glioblastoma

BACKGROUND: Epidermal growth factor receptor (EGFR) gene alterations and amplification are frequently reported in cases of glioblastoma (GBM). However, EGFR-activating mutations that confer proven sensitivity to tyrosine kinase inhibitors (TKIs) in lung cancer have not yet been reported in GBM. CASE...

Descripción completa

Detalles Bibliográficos
Autores principales: Loriguet, Lea, Morisse, Mony Chenda, Dremaux, Julie, Collet, Louison, Attencourt, Christophe, Coutte, Alexandre, Boone, Mathieu, Sevestre, Henri, Galmiche, Antoine, Gubler, Brigitte, Chauffert, Bruno, Trudel, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180520/
https://www.ncbi.nlm.nih.gov/pubmed/30305059
http://dx.doi.org/10.1186/s12885-018-4873-9

Ejemplares similares

Ejemplares similares